A contract research organization’s lawsuit alleging that FDA and its employees damaged its business should be dismissed because it threatens to undermine the agency’s public health mission and the Food, Drug and Cosmetic Act, and the alleged claims are barred by sovereign immunity and exceptions to the Federal Tort Claims Act (FTCA), defendants say.
A federal judge will hear oral arguments Jan. 15 on FDA’s request to throw out a lawsuit by Semler Research...





